News

Regeneron Pharmaceuticals, Inc. announced detailed results from a Phase 2 proof-of-concept trial evaluating the investigational antibody cocktail REGN1908-1909 in cat-allergic patients with mild asthma. The trial met the primary endpoint of preventing early asthma reactions (EAR, defined as a...

Cainiao Smart Logistics Network, and Saudia Cargo are teaming up on five weekly flights from Hong Kong to Liege in Belgium, with Riyadh city as a connection point. The partnership, which starts today, aims to form a sky bridge linking...

Cathay Pacific Cargo is using its Vaccine Solution pharma service to transport large numbers of Covid-19 vaccines, under varying required conditions, to destinations in its network. Yesterday, the carrier carried 1m vaccine doses manufactured by Fosun Pharma/BioNTech from Frankfurt to...

The U.S. government has agreed to purchase a minimum of 100,000 doses of bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company announced. Bamlanivimab and etesevimab together recently received emergency use authorization for the...

Junshi Biosciences, a leading innovation-driven biopharmaceutical company, announced that the company has entered into an exclusive promotion agreement with AstraZeneca Pharmaceutical Co., Ltd, pursuant to which Junshi Biosciences will grant AstraZeneca Pharmaceutical the exclusive promotion right of toripalimab in...

Novo Nordisk announced plans to invest DKK 500 million in expanding facilities at its production site in Måløv, Denmark. The facility currently manufactures products for oral diabetes treatment and will be expanded to ensure capacity for future production of these...

Construction is underway for a new cell therapy manufacturing facility in Devens, MA, a part of Bristol Myers Squibb’s significant investment to support clinical and commercial manufacturing of transformative cell therapies for patients with aggressive hematological cancers. The Devens site...